Fredrik Tiberg, President and CEO, will give an update on the company's activities, including the ongoing launch of Buvidal® weekly and monthly depots for the treatment of opioid dependence.

Camurus is giving a presentation on Aktiespararnas event Aktiedagen in Lund on 29 January 2019. For more information, visit aktiespararna.se.

Stockholm 5-6 March 2019

Vienna. March 25-27 2019
bioeurope.com

The Annual General Meeting in Camurus AB (publ), Reg.No. 556667-9105 will be held on Thursday May 9, 2019, at 17.00 CET at Elite Hotel Ideon, Scheelevägen 27, Ideon Science Park, Lund, Sweden. Camurus AB Ideon Science Park SE-223 70 Lund Sweden

San Francisco. 7-10 January 2019
The J.P. Morgan Healthcare Conference brings together corporate leaders, financial sponsors and institutional investors within the life science industry to explore market and sector trends.
jpmorgan.com

Camurus invites investors, analysts and media to a Capital Markets and R&D Day in Stockholm starting at 1 pm on 11 December 2018. The event will provide updates on Camurus’ key pipeline programs as well as the launch preparations for Buvidal® (CAM2038) in Europe, Australia and the US. A webcast of the event is available at camurus-cmd-2018.com

London. November 14-15 2018. Fredrik Tiberg, President and CEO, is presenting at Jefferies London Healthcare Conference. A webcast of the presentation can be accessed via: jefferies.com.